|
|
 
LipoSonix TechnologyLipoSonix is taking a rigorous, science-based approach to technology development. Patient safety and integrity of clinical data are of paramount importance in all clinical studies conducted by the company LipoSonix achieves targeted reduction of adipose tissue by precisely focusing high intensity ultrasound energy to cause disruption. A custom designed ultrasound transducer delivers energy across the skin surface at a relatively low intensity, but brings this energy to a sharp focus in the subcutaneous fat. At the skin surface, the intensity of the ultrasound energy is low enough so that no damage occurs. The focusing of the ultrasound beam at specific depths beneath the epidermis, combined with proprietary application techniques, results in adipose tissue disruption.¹ Once adipocytes have been disrupted, chemotactic signals activate the body's inflammatory response mechanisms. Macrophage cells are attracted to the area to engulf and transport the lipids and cell debris. This results in an overall reduction in local adipose tissue volume. ² The goal is to achieve precision that will result in effective non-invasive body sculpting. LipoSonix has exclusively licensed two important patents, including the seminal patent in the field. The company has filed a number of additional patent applications on related methods and technology, and continues to work to expand and strengthen this portfolio.
LipoSonix Abstracts Plastic Surgery 2005 M0002 (PDF, 88K) M0003 (PDF, 32K) American Academy of Dermatology 2006 M0008 (PDF, 212K) American Society for Aesthetic Plastic Surgery 2006 M0011 (PDF, 184K) M0012 (PDF, 204K) Plastic Surgery 2006 M0013 (PDF, 112K) |
